Pharmacokinetics and Clinical Response of Tolvaptan in Neurocritical Care Patients

Stopped early

Conditions studied: Brain Injury, Hyponatremia

In brief

To assess the pharmacokinetic profile of tolvaptan in critically ill acute brain injury patients and to secondarily evaluate the clinical response and safety of tolvaptan in acute brain injured patients

Key facts

Study ID
NCT02215148
Run by
University of North Carolina, Chapel Hill
People needed
1
Starts
2014-11-01
Expected to finish
2016-08-01
Last updated by the study team
2016-09-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.